Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

Advertisement

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

July 2024 Dispatch for the CV Team

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

JACC Statement Focuses on PAD Disparities, Gaps in Care

October 2023 News Roundup

Only Half of Revascularized PAD Patients Receive GDMT

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Top Endovascular News of 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

PAD Significantly Ups Morbidity and Mortality in AMICS

December 2021 News Roundup

September 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content